About 200 reports

  • IMMUNOLOGY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUES FOR CIMZIA ($BN), 2006-2022
  • IMMUNOLOGY, GLOBAL, ANNUAL REVENUE FORECAST FOR UPADACITINIB ($M), 2015-2022

Gastrointestinal Cancer Research; ##(##): ##-## Mayo Clinic (2014).

  • Immunology
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • Establish ed
  • 4.2 Key Therapy Areas by Indication

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth and...

  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • Market Size

Report Title Published Date ##.

  • Immunology
  • North America
  • United States
  • World
  • Horizon Discovery
  • Pipeline Landscape Assessment

Excluded from this report are Crohn' s disease and ulcerative colitis, as they fall under the gastrointestinal disorders therapy area.

  • Immunology
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG
  • Central Nervous System
  • Research Contact: info@globaldata.com

Besides, one PE deal worth USD##m was recorded in Q## 2017.

  • Immunology
  • Neurology
  • World
  • Company
  • Deals & Alliance
  • Research Contact: info@globaldata.com

Besides, one VC deal worth USD##. ##m was reported in Q## 2016.

  • Endocrine Disease
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, ORGAN-SPECIFIC SYMPTOMS OF ACUTE GVHD, 2018
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, ORGAN-SPECIFIC SYMPTOMS OF CHRONIC GVHD, 2018

Ulcerative colitis and CD are similar in that they are chronic, inflammatory gastrointestinal diseases, but they can be differentiated from one another by the location of the affected area of the gastrointestinal tract, and by the differences in histological features of th

  • Healthcare
  • Immunology
  • World
  • Company Financials
  • Forecast

In the AR## arm, ##. ##% of patients discontinued due to investigator-reported adverse events, including ##. ##% due to gastrointestinal adverse events and ##. ##% due to systemic allergic hypersensitivity reactions.

  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Aimmune Therapeutics, Inc.

## ## ## United States ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## France ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## Canada Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative
  • TARGETS AND PARTNERS
  • Montreal

Paladin Labs Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Paladin Labs Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A),...

  • Immunology
  • Pharmaceutical
  • Canada
  • M&A
  • Paladin Labs Inc.
  • TARGETS AND PARTNERS
  • ADVISOR INFORMATION

Paladin Labs Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Paladin Labs Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A),...

  • Immunology
  • Pharmaceutical
  • Canada
  • M&A
  • Paladin Labs Inc.

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Immunology
  • Therapy
  • World
  • Product Initiative

## ## ## ## ## ## ## Danone SA United Pharmaceuticals SAS ## ## ## ## ## ## ## ## ## ## ## ## ## ## DBV Technologies SA ## ## ## ## ## ## ## Danone Research BV ## ## ## ## ## ## ## Biosearch Life ## ## ## ## ## ## ## FrieslandCampina Innovation Interna

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • Japan
  • World
  • Clinical Trial profile. 532 Trial Title
  • Clinical Trial profile. 883 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Blood Disease
  • Immunology
  • Pharmaceutical
  • Transplantation
  • World

The company develops drugs in areas of pain, central nervous system and gastrointestinal disorders.

  • Immunology
  • Pharmaceutical
  • United States
  • M&A
  • Salix Pharmaceuticals, Ltd.

RedHill will bear part of the drug' s development costs up to $## million.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • IntelGenx Corp.

The company develops drugs in areas of pain, central nervous system and gastrointestinal disorders.

  • Immunology
  • Pharmaceutical
  • United States
  • M&A
  • Salix Pharmaceuticals, Ltd.

The offer is now scheduled to expire on April ##, 2011.

  • Healthcare
  • Immunology
  • Neurology
  • Pharmaceutical
  • Genzyme Corporation
  • PARTNERSHIP - DEAL REPORTS

By using this product, patients can avoid serious gastrointestinal problems.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Valeant Pharmaceuticals International, Inc.
  • MERGERS AND ACQUISITIONS - DEAL REPORTS

Deal in brief The transaction is expected to close on October ##, 2014.

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Recipharm Group
  • PARTNERSHIP - DEAL REPORTS

It is headquartered in PARTNER ##: ASTELLAS PHARMA INC.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.
  • Ticker symbol
  • PARTNERSHIP - DEAL REPORTS

Cinitapride is an orthopramide with prokinetic activity on the gastrointestinal tract with marked DEAL IN BRIEF procholinergic action that improves gastrointestinal motility.

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Almirall, S.A.
  • PARTNERSHIP

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion COMPANY INFORMATION: PARTNERS PARTNER ##: F.

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Becton Property Group
  • PARTNERSHIP - DEAL REPORTS

Partner ##: Pfizer Inc.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Mylan Inc.

The offer is now scheduled to expire on April ##, 2011.

  • Healthcare
  • Immunology
  • Neurology
  • Pharmaceutical
  • Genzyme Corporation
  • PARTNERSHIP - DEAL REPORTS

By using this product, patients can avoid serious gastrointestinal problems.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Valeant Pharmaceuticals International, Inc.
  • Pipeline Products by Therapy Area and Proportion of Established and First-in-
  • First-in-class Pipeline Products by Therapy Area and Stage of Development, Q1

Health Affairs; ##(##): ##-## Vernon J, et al. (2010).

  • Immunology
  • Pharmaceutical
  • United States
  • Company
  • Deals & Alliance

PARTNER ##: H.

  • Healthcare
  • Immunology
  • Pharmaceutical
  • M&A
  • Myriad Genetics, Inc.

(INACTIVE)) DEAL FINANCIALS COMPANY INFORMATION: TARGET TARGET ##: TARGACEPT, INC.

  • Healthcare
  • Immunology
  • Neurology
  • Pharmaceutical
  • Catalyst Biosciences, Inc.